Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
873 CHF | -0,46 % | -0,46 % | +1,57 % |
02/04 | Actualización de las fuertes variaciones del día: Voltalia y Equasens sonríen | |
02/04 | El consejero delegado de Siegfried dimite; el jefe de finanzas es nombrado consejero delegado interino | MT |
Resumen de negocios
Número de empleados: 3 945
Ventas por actividad
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Substances
67,6
%
| 754 | 61,3 % | 860 | 67,6 % | +14,10 % |
Drug Products
32,4
%
| 476 | 38,7 % | 412 | 32,4 % | -13,51 % |
Ventas por región
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Switzerland
100,0
%
| 1 230 | 100,0 % | 1 271 | 100,0 % | +3,41 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Wolfgang Wienand
CEO | Chief Executive Officer | 52 | 01/08/10 |
Reto Suter
DFI | Director of Finance/CFO | 53 | 01/05/17 |
Jürgen Roos
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/04/19 |
Christa Brügger
PRN | Corporate Officer/Principal | - | 01/02/14 |
Corporate Officer/Principal | 57 | 01/01/21 | |
Irene Wosgien
HRO | Human Resources Officer | 51 | 01/01/21 |
Marianne Späne
PRN | Corporate Officer/Principal | 61 | 01/06/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Martin Schmid
BRD | Director/Board Member | 55 | 01/01/16 |
Wolfram Carius
BRD | Director/Board Member | 63 | 01/01/14 |
Andreas Casutt
CHM | Chairman | 61 | 01/01/10 |
Beat Walti
BRD | Director/Board Member | 55 | 13/04/22 |
Isabelle Welton
BRD | Director/Board Member | 61 | 01/01/20 |
Alexandra Brand
BRD | Director/Board Member | 53 | 13/04/22 |
Director/Board Member | 50 | 20/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 513 000 | 3 957 148 ( 87,68 %) | 223 653 ( 4,956 %) | 87,68 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
SIEGFRIED HOLDING AG 5.01% | 223 811 | 5.01% | 228 855 259 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Siegfried AG
Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The private company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG. |
Chemicals: Agricultural
|
Siegfried (USA), Inc.
Siegfried (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried (USA), Inc. is a private company that manufactures and supplies pharmaceutical products. The company is based in Pennsville, NJ. |
Pharmaceuticals: Major
|
Siegfried Hameln GmbH
Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany. |
Pharmaceuticals: Major
|
BASF PharmaChemikalien GmbH & COKG
BASF PharmaChemikalien GmbH & COKG Chemicals: Major DiversifiedProcess Industries Part of Siegfried Holding AG, BASF PharmaChemikalien GmbH & COKG is a German company that offers innovative products to meet the current and future needs of businesses and society. The private company is based in Ludwigshafen, Germany. The company's product range can be found through industry research or their product search. The company's goal is to grow profitably and create value for society by creating chemistry for a sustainable future. |
Chemicals: Major Diversified
|
Siegfried Finance AG
| |
BASF Pharma (St. Vulbas) SAS
BASF Pharma (St. Vulbas) SAS Chemicals: SpecialtyProcess Industries BASF Pharma (St. Vulbas) SAS manufactures basic organic chemicals. The company is headquartered in Saint-Vulbas, France. |
Chemicals: Specialty
|
Siegfried St. Vulbas SASU
Siegfried St. Vulbas SASU Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried St. Vulbas SASU is a pharmaceutical and French chemical company that offers integrated partnership benefits to its customers. The private company is based in Saint-Vulbas, France. The company combines a long tradition of pharmaceutical and chemistry with the innovative approach of an "integrated supplier" to provide more synergy, expertise, and value. The company was founded in 1992. Philippe Moy has been the CEO of the company since 2020. |
Pharmaceuticals: Major
|
Siegfried PharmaChemikalien Minden GmbH
Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The private company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. |
Chemicals: Specialty
|
Siegfried Evionnaz SA
|
Ventas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,57 % | 4115,84 M | |
+25,61 % | 660 mil M | |
+23,38 % | 562 mil M | |
-5,24 % | 358 mil M | |
+16,49 % | 322 mil M | |
+8,28 % | 297 mil M | |
+12,53 % | 219 mil M | |
-9,86 % | 196 mil M | |
+6,86 % | 199 mil M | |
-8,75 % | 149 mil M |
- Bolsa de valores
- Acciones
- Acción SFZN
- Empresa Siegfried Holding AG